Greg Studdard

Greg Studdard serves as the Chief Business Officer at BioFluidica, Inc. since June 2023, where the focus is on developing liquid biopsy lab systems and tests for various medical markets. Prior to this role, Studdard founded and led Genetics Consulting Services as CEO, specializing in diagnostics and genetics consulting. Previous positions include CEO of Total Sono, where efforts were directed towards enhancing maternal-fetal medicine services, and National Director of Strategic Accounts at Biora Therapeutics, managing genetics testing for maternal-fetal medicine specialists. Additionally, Studdard has held executive positions at Baebies, DiabetOmics, Illumina, and Alere Inc., accumulating extensive experience in sales, marketing, and commercial growth within the healthcare sector. Studdard holds an MBA from Chadwick University and a BS in Marketing, Management, and Psychology from the University of Virginia.